Medical Letter on the CDC & FDA articles from November 2003

Medical Letter on the CDC & FDA archives from November 2003

Human hookworm maintained through 100 generations in golden hamsters.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- "The human hookworm Necator americanus was maintained through one hundred generations in the golden hamster (Mesocricetus auratus)," researchers in China and the United States report. "The parasite...

Growing HIV-1 epidemic reducing multidrug-resistant TB control in Latvia.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- The growing HIV-1 epidemic is adversely affecting the ability of authorities to control multidrug-resistant tuberculosis in Latvia. "Latvia, a country with levels of multidrug-resistant (MDR) TB...

New progestins offer multiple benefits to women's health.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- New progestins offer multiple benefits to women's health. "The need for safe and efficacious hormone use underlines the importance of long-term contraceptive options as well as safe short-term...

Polybrominated and polychlorinated compounds found in human breast milk.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Polybrominated diphenyl ethers, polychlorinated biphenyls, polychlorobiphenylols, and pentachlorophenol were found in human breast milk and in the blood of pregnant women. According to recent...

E. coli O157:H7 and Shigella sonnei express green fluorescent protein.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Endogenous host plasmids were used for generation of Escherichia coli O157:H7 and Shigella sonnei strains that stably express the green fluorescent protein. According to a study from the United...

Antibody responses to Wolbachia surface protein characterized.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- The antibody responses to Wolbachia surface protein have been characterized in humans with lymphatic filariasis. "Symbiotic Wolbachia organisms of filarial nematodes have received much attention as...

Correcting misperceptions can curb student drinking.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Cutting alcohol consumption among college students nationwide is not only desirable, but also possible. A unique new University of North Carolina at Chapel Hill (UNC) study concludes that correcting...

IMPAX receives approval for generic Claritin Reditabs.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- IMPAX Laboratories, Inc., (IPXL) announced that the U.S. Food and Drug Administration (FDA) has granted approval to the company's abbreviated new drug application (ANDA) for a generic version of...

Taking aim at bioterrorism: Professor gets HHS funding.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Selected to play a vital role in confronting the threat of bioterrorism, University of Houston (UH) professor Steven Blanke has a particular target in mind: anthrax. Blanke, an associate professor...

Year-long follow-up finds no further postal workers affected.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Findings from the U.S. Centers for Disease Control and Prevention (CDC) indicate that the rates and causes of death among the United States Postal Service employees during the 12 months following the...

Traumatic brain injury treatment receives FDA fast track designation.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Pharmos Corporation (PARS) announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation for dexanabinol for treatment of severe traumatic brain injury (TBI). In its...

Second part of rolling NDA submitted for RSR13.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Allos Therapeutics, Inc., (ALTH) announced that it has submitted to the U.S. Food and Drug Administration (FDA) the second of three data components of the New Drug Application (NDA) for its radiation...

FDA reconsiders silicone-gel implants.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Eleven years after most use of silicone-gel breast implants was banned amid fears they were dangerous, the U.S. Food and Drug Administration (FDA) is considering letting them back on the U.S. market....

FDA puts phase III trial of antianxiety product on hold.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- DOV Pharmaceutical, Inc., (DOV) announced that the U.S. Food and Drug Administration (FDA) placed the start of the phase III trial of ocinaplon, DOV's novel anti-anxiety product candidate, on hold. ...

Data submitted to FDA for clearance to market test to monitor colon cancer.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- AMDL, Inc., (ADL) has filed with the U.S. Food and Drug Administration for clearance to market its unique, proprietary DR-70 tumor marker test for use as an aid in monitoring patients previously...

FDA approves Inspra for improving survival of patients after a heart attack.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has approved Inspra (eplerenone) tablets for improving the survival of congestive heart failure patients following an acute heart attack. Inspra is the...

FDA panel recommends non-approval of laser angioplasty.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Spectranetics Corporation (SPNC) announced that the Circulatory System Devices Advisory Panel of the U.S. Food and Drug Administration (FDA) recommended non-approval of the company's Pre-Market Approval...

Dengue fever outbreak occurs in Palau, Western Pacific.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- An outbreak of dengue fever occurred in Palau, in the Western Pacific, in 1995. "Between January and June 1995, an outbreak of dengue fever occurred in Palau, an island nation of 32,000 inhabitants...

FDA issues second approvable letter for Cymbalta.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) issued a second approvable letter for Cymbalta (duloxetine HCl; pronounced SIM-BALL-TA), a potent serotonin and norepinephrine reuptake inhibitor, Eli Lilly...

Regulatory plan reiterated after pre-PMA-S meeting with FDA.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Cyberonics, Inc., (CYBX) reiterated its plan to submit a depression PMA-Supplement (PMA-S) to the U.S. Food and Drug Administration (FDA). Cyberonics' Clinical and Regulatory personnel met with...

FDA approves generic lidocaine/prilocaine cream.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Hi-Tech Pharmacal Co., Inc., (HITK) announced that the company has received approval from the U.S. Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for lidocaine 2.5%...

Potentiometric method used to measure saccharin in sweeteners.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Researchers have developed a potentiometric method to measure saccharin in commercial artificial sweeteners using a silver electrode. According to a study from Brazil, "A simple, precise, rapid and...

Study evaluates effectiveness of ED computers in identifying outbreaks.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- A computerized patient information system in Oregon Health and Science University (OHSU) Hospital's emergency department (ED) may prove effective in helping detect unusual clusters of contagious disease...

Curious and confused: Prescription drug ads impact consumer health.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Although they generally "like" prescription drug advertising, consumers often don't know what the ads are for, according to University of Arkansas researcher Steve Kopp. His research indicates that...

Resistance patterns of pneumococcal diseases in adults with HIV reported.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Researchers report serotype and antimicrobial resistance patterns of invasive pneumococcal diseases in adults with human immunodeficiency virus infection in the United States. According to...

Global urbanization exerts significant impacts on health.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Global urbanization exerts significant impacts on health. "Nearly half the world's population now lives in urban settlements. Cities offer the lure of better employment, education, health care, and...

High burdens of 2,2',4,4'-tetrabromodiphenyl ether found in California women.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Researchers have found high body burdens of 2,2',4,4'-tetrabromodiphenyl ether (BDE-47) in California women. "Following our first report on elevated polybrominated diphenyl ether (PBDE)...

Impedance method detects bacteria and fungi in bottled purified water.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Researchers report an impedance method for the rapid detection of total counts of bacteria and fungi in bottled purified water. According to recent research from China, "A study was conducted to...

Metabolites of polychlorinated biphenyls reported in human tissues.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Analysts have determined the distribution of methyl sulfone metabolites of polychlorinated biphenyls and p,p'-DDE in human tissues. "We determined methylsulfonyl metabolites of chlorinated...

Company receives tentative approval for generic Topiramate tablets.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- IVAX Corp. (IVX) has received tentative approval from the U.S. Food and Drug Administration for its abbreviated new drug application for Topiramate tablets in 25 mg, 100 mg, and 200 mg strengths. ...

Bioassay and LC-MS methods compared for measuring enrofloxacin in whole eggs.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Researchers report results of a comparison between a bioassay and liquid chromatography-fluorescence-mass spectrometry for the determination of incurred enrofloxacin in whole eggs in a recent issue of...

Lexapro gets approvable letter from FDA.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Forest Laboratories, Inc., (FRX) has received an approvable letter from the U.S. Food and Drug Administration (FDA) to expand the use of Lexapro (escitalopram oxalate) to include the treatment of...

Pharmaceutical company receives tentative approval to manufacture new generics.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Ranbaxy Pharmaceuticals, Inc., (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced that RLL has received tentative approval from the Office of Generic Drugs of the U.S....

NIH announces strategy to accelerate medical research progress.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- In a move to transform the nation's medical-research capabilities and speed the movement of research discoveries from the bench to the bedside, U.S. National Institutes of Health (NIH) director Elias A....

Approval sought for HIV-1 test that detects antibodies in oral fluid or plasma.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- OraSure Technologies, Inc., (OSUR) is filing an application with the U.S. Food and Drug Administration (FDA) for pre-market approval of its OraQuick Rapid HIV-1 Antibody Test for use in detecting HIV-1...

Adenoviral vector HIV vaccine stimulates enhanced mucosal IgA response.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- An intranasal adenoviral vector human immunodeficiency virus vaccine stimulated an enhanced mucosal immunoglobulin A response. According to recent research published in the Journal of Virology,...

DNA vaccine protects against hantavirus pulmonary syndrome.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Andes virus M genome segment-based DNA vaccine provided active and passive vaccination against hantavirus pulmonary syndrome. "Hantavirus pulmonary syndrome (HPS) is a rapidly progressing human...

Cancer patients without insurance have lower survival rates.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Uninsured cancer patients in Kentucky have lower 3-year survival rates for colorectal, breast, prostate, and lung cancer compared with insured cancer patients, according to an article the Archives of...

Women surpass men in heart disease deaths, U.N. health agency reports.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Contradicting conventional wisdom, the largest-ever worldwide collaborative study of heart disease has found that women are slightly more likely to die from cardiovascular disease (CVD) than men and...

FDA approves humanitarian use device status for AbioCor implantable heart.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Abiomed, Inc., (ABMD) announced that it has received favorable action from the Food and Drug Administration designating the company's first generation AbioCor Implantable Replacement Heart as a...

Service company receives clearance to market sorbent hemodialysis cartridges.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Renal Solutions, Inc., announced receiving 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market their new and enhanced version of the SORB and HISORB sorbent regenerative...

Seroepidemiology of hepatitis B virus in Addis Ababa reported.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- A group of investigators report the transmission patterns and vaccine control levels of hepatitis B virus in Addis Ababa, Ethiopia. According to published research from Ethiopia and Kenya, "A...

SpineJet Curette handpiece gets FDA clearance.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- HydroCision, Inc., announced that the U.S. Food and Drug Administration has granted 510(k) clearance to market its SpineJet Curette device for open and minimally invasive spine surgery. The...

CDC partners with University of Liverpool for research alliance.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Invest.UK, the British government's worldwide inward investment agency, announced that the U.S. Centers for Disease Control and Prevention (CDC) has signed a formal memorandum of understanding with the...

Hantavirus epidemiology in Argentina characterized.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- The prevalence and transmission dynamics of hantaviruses in Argentina have been characterized. Scientists there conducted a study "to elucidate the ecology and epidemiology of hantavirus...

Scottish foot and mouth epidemic reduces human cryptosporidiosis rate.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- A Scottish foot and mouth epidemic has been linked to a reduction in the rate of cryptosporidiosis in humans. "In Scotland, rates of cryptosporidiosis infection in humans peak during the spring, a...

Texas joins CDC's Emerging Infections Program network.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Texas has become the 11th Emerging Infections Program (EIP) site in the United States. The U.S. Centers for Disease Control and Prevention (CDC) established EIP sites in 1995 as part of the agency's...

FDA panel issues favorable recommendation for Luveris in follicular development.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Serono, Inc., announced that the Reproductive Health Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) issued a favorable recommendation for Luveris in Serono's proposed indication...

CDC outlines racial/ethnic disparities in elderly vaccine recipients.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Elderly blacks and Hispanics are less likely to receive influenza and pneumococcal vaccinations than are whites, according to the U.S. Centers for Disease Control and Prevention (CDC). Both...

Child restraint seats in airplanes could cause more deaths than they prevent.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- A proposal requiring that children under 2 years old have their own airplane seats and use child restraint systems (CRSs, similar to children's car seats), may cause an increase in deaths if enough...

Guns may hold "unique allure" for young boys.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Many boys say they are not interested in playing with guns and may even describe them as their least favorite object in a group of play items, but many will still touch a gun if left alone with one, new...

Report: Home visits can reduce child abuse, gun control may not lessen violence.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- The two newest sets of findings from the U.S. Centers for Disease Control and Prevention's (CDC) Guide to Community Preventive Services (Community Guide) add new depth to what is known about strategies...

FDA clearance granted to market InstaRead rapid test for psychiatric use.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Akers Biosciences, Inc., announced that it has received market clearance from the U.S. Food and Drug Administration (FDA) that will allow the company to market one format of its rapid test system for...

FDA special protocol assessment review for Telcyta completed.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Telik, Inc., (TELK) announced that the phase III protocol for Telcyta (TLK286) in non-small cell lung cancer (NSCLC) has successfully completed Special Protocol Assessment review by the U.S. Food and...

Vaccine based on Pichia pastoris shows promise against malaria.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- A vaccine based on the F2 domain of the Plasmodium falciparum erythrocyte binding antigen expressed in Pichia pastoris shows promise against malaria. According to recent research published in the...

Even in WNV epizootic areas, enteroviruses still main cause of meningitis.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Even in WNV epizootic areas, enteroviruses still main cause of meningitis. "While enteroviruses have been the most commonly identified cause of aseptic meningitis in the United States, the role of...

FDA approves new Zomig (zolmitriptan) nasal spray formulation.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- AstraZeneca (AZN) announced that the U.S. Food and Drug Administration (FDA) has approved Zomig (zolmitriptan) Nasal Spray (5.0 mg) for the acute treatment of migraine with or without aura in adults....

Company may get $3M more from Defense Department for health-monitoring vest.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Foster-Miller, Inc., announced that the U.S. Department of Defense has included $3 million in the recently approved 2004 spending bill to further develop a soldier health-monitoring garment that uses...

Veterinary vaccine candidate ChimeriVax-West Nile virus grown in mosquitoes.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- The growth characteristics of the veterinary vaccine candidate ChimeriVax-West Nile (WN) virus in Aedes and Culex mosquitoes have been published in a recent issue of Medical and Veterinary Entomology....

Agreement reached on STR phase III registration trial.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- NeoRx Corp. (NERX), a cancer-therapeutics development company, has reached agreement with the U.S. Food and Drug Administration (FDA), under the special protocol assessment (SPA) process, on the design...

Sodium oxybate has gone from club drug to orphan drug to treat cataplexy.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Sodium oxybate (Xyrem) has gone from club drug to orphan drug in the treatment of cataplexy. "Narcolepsy, a rare disease with a prevalence of 0.05% in the general population, affects an estimated...

At current rate of decline, smoking prevalence will not meet 2010 goal.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Comprehensive tobacco control programs at the state level have helped to reduce tobacco use, says the U.S. Centers for Disease Control and Prevention (CDC). One of the national health objectives for...

Company initiates NDA submission for Onco TCS.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Inex Pharmaceuticals Corp. (IEX) announced that it has commenced a "rolling submission" by submitting the first of three major sections of a new drug application (NDA) to the U.S. Food and Drug...

Vitamin D deficiency emerges as new epidemic.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Medical experts are talking about a new health epidemic - one that most thought was eliminated decades ago. It's a lack of vitamin D. The surprising deficiency is increasing the risk of osteoporosis and...

Prevalence of severe obesity increasing faster than obesity in the U.S.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- The number of clinically severe obese people in the United States is increasing faster than the obese population, according to new research. Various studies in the United States have documented that...

Candida rugosa may be emerging human pathogen.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Candida rugosa may be an emerging pathogen, especially in patients undergoing surgery or other invasive procedures. C. rugosa "has been rarely reported as a human pathogen," scientists in Brazil...

Automated, laboratory-based system to detect disease outbreak developed.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- An automated, laboratory-based system using the Internet for disease outbreak detection has been developed in the Netherlands. "Rapid detection of outbreaks is recognized as crucial for effective...

Laboratory electronic reporting inadequate for bioterrorist attack.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Current electronic laboratory reporting systems would likely be inadequate in the event of a bioterror attack. "While newly available electronic transmission methods can increase timeliness and...

Group counsels patients on self-treatment.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- A new education campaign by the surgeon general and a mix of pharmacy and consumer groups aims to help patients become more savvy about self-treatment. Over-the-counter medicines often are powerful...

Senate confirms ex-Lilly executive as White House AIDS coordinator.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- The U.S. Senate confirmed a former chief executive officer of Eli Lilly & Co. to be the White House's coordinator in the international battle against AIDS. Randall Tobias, former CEO of the...

New vaccine for children reduces severe infection from common bacteria.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- A new study of 16 Massachusetts communities found that 8% of children under age 7 carry antibiotic-resistant S. pneumoniae, a bacterium commonly found in healthy children but which presents a low risk...

FDA accepted DepoMorphine NDA for filing.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Endo Pharmaceuticals, Inc., a wholly owned subsidiary of Endo Pharmaceuticals Holdings, Inc., (ENDP), announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug...

Rx Depot case one of savings vs. safety.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Shutting down a firm that links seniors with low-cost medication from Canada would create a "domino effect," leaving Americans nationwide without access to drugs they can afford, the company's lawyer...

Functional analysis of C-TAK1 substrate binding reported.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Researchers report the results of a functional analysis of C-TAK1 substrate binding and identification of PKP2 as a new C-TAK1 substrate in a recent issue of the EMBO Journal. "Cdc25C-associated...

New light unit assembly expands phototherapy applications.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Radiancy, Inc., a company focused on light-based skin therapies, has expanded the treatment applications for its LHE (light heat energy) phototherapy systems by introducing a new light unit assembly...

Survey: Public misjudges greatest threat to the nation's health.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Despite recent intense media coverage of public-health issues ranging from bioterrorism to SARS to obesity, most Americans still do not recognize the greatest public-health threat to the nation, finds...

Skunk and raccoon rabies in the eastern United States followed.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Researchers have released a temporal and spatial analysis of skunk and raccoon rabies in the eastern United States. According to recent research published in the journal Emerging Infectious...

FDA stops sale of supplements making misleading claims about obesity, impotence.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) announced that on September 22, 2003, U.S. District Court Judge Robert J. Vining Jr. entered a Consent Decree of Permanent Injunction against Hi-Tech...

Permanent code assigned for reimbursement of capsule endoscopy.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Given Imaging, Ltd., (GIVN) announced that the American Medical Association (AMA) has assigned a permanent CPT (current procedural terminology) code for reimbursement of capsule endoscopy, effective...

Company files Numax investigational new drug application.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- MedImmune, Inc., (MEDI) announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration to evaluate Numax as a potential new product to help...

Milestone achieved with filing of IND application for Numax.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Applied Molecular Evolution, Inc., (AME, AMEV) announced that it has achieved a milestone triggered by MedImmune, Inc.'s, filing of an Investigational New Drug Application (IND) with the U.S. Food and...

CDC: SARS fear may swamp emergency rooms.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Fear over the possible return of SARS is so great in the United States that even if the virus does not appear, it will probably cause disruptions in hospitals this winter, top U.S. health officials say....

Contract awarded from NIH for development of SARS vaccine.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Baxter Healthcare Corporation announced that it has been awarded a $10 million contract by the National Institute of Allergy and Infectious Diseases (NIAID) to develop and produce an inactivated...

Study shows disease in kids tends to be mild.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- New SARS data suggest that infected pregnant women may be prone to premature childbirth, but their babies may face a low risk of developing the disease. A second study bolsters evidence that...